Global and national estimates of disability-adjusted life years (DALYs) due to <i>Klebsiella pneumoniae</i>-associated lower respiratory infections in 1990 and 2021. by Juanjuan Li (399633)

Subjects:

DALYs rate and SDI across all regions between1990 and 2021 (a). DALYs rate across all countries in 2021 by SDI (b). DALYs disability-adjusted life years, SDI socio-demographic inde... by Juanjuan Li (399633)

Subjects:

The number and ASR of deaths for <i>Klebsiella pneumoniae</i>-related LRI burden in 1990 and 2021, and its trends from 1990 to 2021. by Juanjuan Li (399633)

Subjects:

The global disease burden of <i><i>Klebsiella pneumoniae</i></i> associated LRI for both sexes in 204 countries and territories. (a) The number of deaths in 2021; (b) The EAPC of d... by Juanjuan Li (399633)

Subjects:

The number and ASR of DALYs for <i>Klebsiella pneumoniae</i>-related LRI burden in 1990 and 2021, and its trends from 1990 to 2021. by Juanjuan Li (399633)

Subjects:

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…In addition, compound <b>E35</b> significantly inhibited colony formation and migration, as well as arrested the cell cycle at the S-phase. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…In addition, compound <b>E35</b> significantly inhibited colony formation and migration, as well as arrested the cell cycle at the S-phase. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…In addition, compound <b>E35</b> significantly inhibited colony formation and migration, as well as arrested the cell cycle at the S-phase. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…In addition, compound <b>E35</b> significantly inhibited colony formation and migration, as well as arrested the cell cycle at the S-phase. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…In addition, compound <b>E35</b> significantly inhibited colony formation and migration, as well as arrested the cell cycle at the S-phase. …”

Sex-specific and age-specific crude cumulative incidence and rate ratio of hemorrhagic stroke and CVST during the pre-pandemic (2007–2019) and pandemic (2020–2022) periods. by Soo Hyeon Cho (19797394)

Summary of time-series correlation analyses between hemorrhagic stroke & CVST and known risk factors during the pre-pandemic (2007–2019) and pandemic (2020–2022) periods. by Soo Hyeon Cho (19797394)

NbUCH positive regulates RipE1 accumulation in <i>N. benthamiana.</i> by Wenjia Yu (9422059)

Key characteristics of non-healed DU wound records at adopted branches in 2022 and 2023. by Heba Tallah Mohammed (2822432)

Subjects:

Overall characteristics of wound records at adopted branches in 2022 and 2023. by Heba Tallah Mohammed (2822432)

Subjects:

Relative Index of Inequality (RII) and 95% Confidence Interval (CI) for access question between most a least deprived SIMD decile by A) Age and sex B) Number of Health Issues and c... by David Henderson (4612354)

Subjects:

Primer sequences for qPCR. by Tucker Hopkins (20790529)

Subjects:

FDA-approved reference marker and capturing wound image. by Heba Tallah Mohammed (2822432)

Subjects:

Longitudinal assessment of animal weights and tumor metrics. by Robert Botelho (20308297)

Subjects:

Spatial exploration patterns of non-tumor bearing mice under different treatment conditions in the Morris Water Maze (MWM). by Robert Botelho (20308297)

Subjects: